Human Protein C Polypeptide

Details for Australian Patent Application No. 2003252774 (hide)

International Classifications

Event Publications

23 October 2003 Complete Application Filed

6 November 2003 Application Open to Public Inspection

Published as AU-A-2003252774

20 May 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

29 July 2004 Section 223 Application Allowed

Eli Lilly and Company The time in which to request examination has been extended to 30 May 2004. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2004

22 December 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.